Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D05OHF
|
||||
| Former ID |
DNC013758
|
||||
| Drug Name |
(R)-(+)-coclaurine
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [534656] | ||
| Formula |
C17H19NO3
|
||||
| Canonical SMILES |
COC1=C(C=C2C([NH2+]CCC2=C1)CC3=CC=C(C=C3)O)O
|
||||
| InChI |
1S/C17H19NO3/c1-21-17-9-12-6-7-18-15(14(12)10-16(17)20)8-11-2-4-13(19)5-3-11/h2-5,9-10,15,18-20H,6-8H2,1H3/p+1/t15-/m1/s1
|
||||
| InChIKey |
LVVKXRQZSRUVPY-OAHLLOKOSA-O
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | D(2) dopamine receptor | Target Info | Inhibitor | [534656] | |
| Dopamine D1 receptor | Target Info | Inhibitor | [534656] | ||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
| Dopamine receptor mediated signaling pathway | |||||
| Nicotine pharmacodynamics pathwayP05912:Dopamine receptor mediated signaling pathway | |||||
| PathWhiz Pathway | Dopamine Activation of Neurological Reward System | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.